Status:
NOT_YET_RECRUITING
Comparison of the Systematic Versus the Selective Use of Heparin for the Prevention of Radial Artery Occlusion
Lead Sponsor:
Olivier F. Bertrand
Conditions:
Radial Artery Occlusion
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Randomized study comparing the systematic use of heparin (standard of care) against an elective use of heparin to prevent radial artery occlusion after a percutaneous catheterization using a dual-arte...
Eligibility Criteria
Inclusion
- Any patient referred for a diagnostic transradial catheterism
Exclusion
- Unable to understand study design or provide informed consent
- Unable to receive antiplatelet therapy with aspirina and/or clopidogrel-prasugrel and/or ticagrelor and intravenous anticoagulant derived from heparine or bivalirudine
- Local condition such as hematoma or pseudo-aneurims precluding radial or ulnar access.
- Presence of plethysmographic waveform with simultaneous radial and ulnar occlusive compression (due to colaterals or interouseous artery) precluding the evaluation of patent hemostasis.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06981624
Start Date
May 1 2025
End Date
December 1 2026
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IUCPQ
Québec, Quebec, Canada, G1V4G5